• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Adaptive servo ventilation versus continuous or bi-level positive airway pressure: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Priorization for patients on waiting lists: development of a generic system]
2012     HAYES, Inc. Somatosensory evoked potentials (SEPs) for intraoperative monitoring during spinal cord surgery for trauma or tumors
2012     Basque Office for Health Technology Assessment (OSTEBA) [Assistance at normal childbirth. Guide for pregnant women, future parents, as well as their partners and relatives]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Electronic cigarettes: a review of the clinical evidence and safety
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Digital hearing aid in comparison with analog hearing aid for presbycusis: evaluation of the clinical effectiveness and the cost-effectiveness]
2012     HAYES, Inc. Sphincter pharyngoplasty for velopharyngeal insufficiency in children
2012     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 1 diabetes]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Therapy dogs and horses for mental health: a review of the clinical effectiveness
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline of care for people with multiple sclerosis]
2012     HAYES, Inc. Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2012     Basque Office for Health Technology Assessment (OSTEBA) [They just told me I have diabetes! Guide for youth and adults with type 1 diabetes and in intensive treatment]
2012     Medical Advisory Secretariat (MAS) Chronic Obstructive Pulmonary Disease (COPD)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Drug eluting stents in adults with in-stent restenosis: a review of the clinical effectiveness, safety and guidelines
2012     Andalusian Health Technology Assessment Area (AETSA) [Safety and effectiveness of oncolytic viruses in advanced cancer. systematic review of the literature]
2012     HAYES, Inc. Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Bone graft substitutes in traumatology]
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Lymphocyte transformation testing (LTT) or lymphocyte proliferation testing (LPT) for hip or knee arthroplasty: a review of clinical and cost-effectiveness, and evidence-based guidelines
2012     HAYES, Inc. VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Falls prevention for the elderly]
2012     Agency for Healthcare Research and Quality (AHRQ) Enabling patient-centered care through health information technology (Health IT)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2012     Andalusian Health Technology Assessment Area (AETSA) [Extended neonatal screening for lysosomal diseases by mass spectrometry]
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Evaluation of acellular dermal matrix for breast reconstruction: an update
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Dual antiplatelet therapy and enoxaparin or unfractionated heparin for patients with ST-elevation myocardial infarction: a review of the clinical evidence
2012     HAYES, Inc. X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) A systematic review of intravitreal bevacizumab for the treatment of diabetic macular edema
2012     Andalusian Health Technology Assessment Area (AETSA) [New oral anticoagulants for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation]
2012     HAYES, Inc. Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC)
2012     HTA Unit, University of Calgary A health technology assessment of transient elastography in liver disease
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis: clinical effectiveness and harms
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin detemir (Levemir®) 100 U/ml solution for injection
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing pneumonia readmissions
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fidaxomicin (Dificlir®) 200 mg film-coated tablets
2012     Technology Assessment Unit of the McGill University Health Centre (MUHC) Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: a health technology assessment
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing AMI readmissions
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Degarelix (Firmagon®) 80 mg and 120 mg subcutaneous injection
2012     HAYES, Inc. C-abl oncogene 1, nonreceptor tyrosine kinase (ABL1) variant testing in acquired tyrosine kinase inhibitor (TKI) resistance
2012     HAYES, Inc. Massage therapy for autism spectrum disorders in children
2012     Penn Medicine Center for Evidence-based Practice (CEP) Condom catheter use and catheter-associated urinary tract infections
2012     Agency for Healthcare Research and Quality (AHRQ) Measuring health-related quality of life for patients with diabetic retinopathy
2012     HAYES, Inc. CancerTYPE ID® (bioTheranostics Inc.) for cancer of unknown primary (CUP)
2012     Penn Medicine Center for Evidence-based Practice (CEP) Implantable cardiac devices: implications for outpatient endoscopy
2012     Agency for Healthcare Research and Quality (AHRQ) Systematic review of ECG-based signal analysis technologies for evaluating patients with acute coronary syndrome
2012     Penn Medicine Center for Evidence-based Practice (CEP) Medications for treating acutely agitated or aggressive behavior in pediatric emergency patients
2012     Agency for Healthcare Research and Quality (AHRQ) Update on mapping the landscape of genetic tests for non-cancer diseases/conditions
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Alternative methods for the treatment of post-menopausal troubles]
2012     Penn Medicine Center for Evidence-based Practice (CEP) Credentialing for robotic-assisted surgery
2012     Adelaide Health Technology Assessment (AHTA) Television marketing of unhealthy food and beverages to children in Australia: a review of published evidence from 2009
2012     Belgian Health Care Knowledge Centre (KCE) Performance of the Belgian Health System. Report 2012
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [CT coronary angiography versus conventional invasive coronary angiography in CHD]
2012     Penn Medicine Center for Evidence-based Practice (CEP) Reducing heart failure readmissions
2012     Belgian Health Care Knowledge Centre (KCE) Models for citizen and patient involvement in health care policy part I: exploration of their feasibility and acceptability
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Clinical effectiveness and cost-effectiveness of central venous catheters treated with minocycline and rifampicin in preventing bloodstream infections in intensive care patients]
2012     Penn Medicine Center for Evidence-based Practice (CEP) Transfer of neurointensive care patients
2012     Belgian Health Care Knowledge Centre (KCE) A national clinical practice guideline on the management of localised prostate cancer - Part 1
2012     Belgian Health Care Knowledge Centre (KCE) Manual for cost-based pricing of hospital interventions
2012     Penn Medicine Center for Evidence-based Practice (CEP) Colchicine for prevention of percarditis and atrial fibrilation
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Bypass surgery performed with or without the use of heart-lung machine]
2012     Belgian Health Care Knowledge Centre (KCE) A national guideline for the prevention of pressure ulcers
2012     NIHR Health Technology Assessment programme Mode of data elicitation, acquisition and response to surveys: a systematic review
2012     HAYES, Inc. Screening, Brief Intervention, and Referral to Treatment (SBIRT) using remote interventions for alcohol misuse
2012     Penn Medicine Center for Evidence-based Practice (CEP) Interventions to improve patient satisfaction
2012     Belgian Health Care Knowledge Centre (KCE) Evolution of day care: impact of financing and regulations
2012     Technology Assessment at SickKids (TASK) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness of geriatric rehabilitation among patients with secondary diagnosis dementia]
2012     Penn Medicine Center for Evidence-based Practice (CEP) Inpatient pharmacist interventions: impact on ED visits, readmissions, length of stay, mortality, patient knowledge, medication adherence, and patient satisfaction
2012     Belgian Health Care Knowledge Centre (KCE) Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy
2012     Belgian Health Care Knowledge Centre (KCE) Hepatitis C screening and prevention
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Therapy of the burnout syndrome]
2012     NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: RhinoChill® intranasal cooling device for protective cooling the brain after a cerebral ischaemic event
2012     Belgian Health Care Knowledge Centre (KCE) Organisation of care for chronic patients in Belgium: development of a position paper
2012     NIHR Health Technology Assessment programme A systematic review of the clinical effectiveness and cost effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy
2012     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (Xgeva) for recurrent or unresectable giant cell tumour of the bone – first or second line
2012     Belgian Health Care Knowledge Centre (KCE) Neuromodulation for the management of chronic pain: implanted spinal cord stimulators and intrathecal analgesic delivery pumps
2012     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
2012     HAYES, Inc. Spinal cord stimulation for relief of neuropathic pain
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab (Herceptin) for HER2 positive early breast cancer – two year regimen
2012     Belgian Health Care Knowledge Centre (KCE) Vaccine safety surveillance in Belgium : place and limits of a background rate approach
2012     NIHR Health Technology Assessment programme The measurement of patients' expectations for health care: a review and psychometric testing of a measure of patients' expectations
2012     NIHR Horizon Scanning Centre (NIHR HSC) Palifosfamide tromethamine (Zymafos) for advanced soft tissue sarcoma – first line
2012     HAYES, Inc. Corus® CAD
2012     Belgian Health Care Knowledge Centre (KCE) The use of Qualitative Research Methods in KCE studies
2012     HAYES, Inc. Surgery for treatment of migraine headache
2012     NIHR Horizon Scanning Centre (NIHR HSC) Emepepimut-S (Stimuvax) for non-small cell lung cancer – maintenance therapy
2012     HAYES, Inc. Cytochrome P450 (CYP450) genotyping to predict response to antidepressant and antipsychotic medications
2012     Belgian Health Care Knowledge Centre (KCE) Principles and criteria for the level of patient cost sharing: Reflections on value-based insurance
2012     NIHR Health Technology Assessment programme Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: A systematic review and economic evaluation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Elacytarabine for relapsed or refractory acute myeloid leukaemia – second or third line
2012     HAYES, Inc. Ki-67 (MKI67) proliferation marker testing in ductal carcinoma in situ (DCIS) and breast cancer
2012     Belgian Health Care Knowledge Centre (KCE) Supportive treatment for cancer - part 1: exercise treatment
2012     NIHR Health Technology Assessment programme The effectiveness of interventions to treat severe acute malnutrition in young children: a systematic review
2012     NIHR Horizon Scanning Centre (NIHR HSC) Axitinib (Inlyta) for advanced and/or metastatic renal cell carcinoma – first line
2012     HAYES, Inc. Oncotype DX for the prediction of recurrence of invasive breast cancer
2012     Belgian Health Care Knowledge Centre (KCE) Catheter ablation of atrial fibrillation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2012     HAYES, Inc. Panexia test for hereditary pancreatic cancer
2012     Belgian Health Care Knowledge Centre (KCE) Prophylactic removal of pathology-free wisdom teeth: rapid assessment
2012     HAYES, Inc. Ultrasound guidance to aid in the placement of peripherally inserted central catheter lines